Skip to main content
Clinical Trials/NCT03658512
NCT03658512
Recruiting
Not Applicable

Tübinger Diabetes Mellitus Database (TUEDID)

University Hospital Tuebingen1 site in 1 country1,000 target enrollmentAugust 13, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
University Hospital Tuebingen
Enrollment
1000
Locations
1
Primary Endpoint
Glycemic control (blood glucose)
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Diabetes mellitus is a widespread disease with increasing prevalence worldwide. Patients with diabetes can develop multiple late complications such as neuropathy, retinopathy, nephropathy and cardiovascular comorbidities. So far, there are no reliable predictive tools or markers to estimate if, when and to what extent a patient with diabetes develops late complications. For the patients quality of life and for health economic reasons an improved risk assessment would be desirable. The prospective TUEDID study will characterize diabetic patients to look out for parameters the predict progression of diabetes and its complications.

Registry
clinicaltrials.gov
Start Date
August 13, 2018
End Date
February 1, 2028
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • \>18 years

Exclusion Criteria

  • no written informed consent

Outcomes

Primary Outcomes

Glycemic control (blood glucose)

Time Frame: At enrolment

Assessed as fasting blood glucose and HbA1C

Glycemic control (HbA1C)

Time Frame: At enrolment

Assessed as fasting HbA1C

Study Sites (1)

Loading locations...

Similar Trials